Questions about Brain Metastasis
Can a high neutrophil-to-lymphocyte ratio predict if a lung cancer patient will develop brain metastasis?
Yes, a high neutrophil-to-lymphocyte ratio (NLR) is linked to a higher risk of developing brain metastasis in lung cancer patients, according to a meta-analysis and other studies.
Full answer →How well does osimertinib work for lung cancer patients who have active brain metastasis?
Osimertinib is effective for EGFR-mutated NSCLC patients with active brain metastases, with real-world data showing median progression-free survival of 12.4 months and intracranial responses, though resistance can develop.
Full answer →Is stereotactic radiotherapy an effective treatment option for patients with brain metastasis?
Yes, stereotactic radiotherapy is an effective treatment for brain metastases, offering high local control rates and preserving cognitive function.
Full answer →What are the microenvironment mechanisms that drive lung cancer brain metastasis?
Lung cancer brain metastasis is driven by tumor cells co-opting brain developmental pathways, secreting exosomal CEMIP and LCN2, and recruiting astrocytes and macrophages to create a supportive niche.
Full answer →What are the risks of brain metastasis in patients diagnosed with lung cancer?
Brain metastases are common in lung cancer, especially small cell (15% at diagnosis) and non-small cell types, with elevated neutrophil-to-lymphocyte ratio as a risk factor; targeted therapies like osimertinib show high intracranial response rates.
Full answer →All Brain Metastasis Articles
- NODI parameters ODI and V-ISO differentiate gliomas from brain metastases in contrast-enhancing regions
- ctDNA positivity linked to increased risk of brain metastases in advanced solid tumors
- Local brain therapies associated with reduced mortality in HNSCC patients with brain metastasis
- WBRT shows no significant survival benefit in thyroid cancer brain metastases meta-analysis
- Outpatient rehab improves function in children with brain tumours, but long-term effects unclear
- Adding WBRT to SRS cuts brain metastasis recurrence but raises cognitive decline without survival gain
- Systematic review and meta-analysis finds higher intracranial aneurysm prevalence in pituitary adenoma patients
- Systematic review examines tumor microenvironment mechanisms in lung cancer brain metastases
- 3D C-Vit model improves tumor grading accuracy in 340 pediatric brain tumor cases
- Narrative Review Examines Stereotactic Radiotherapy Use in Cancer Patients With Brain Metastases
- Retrospective observational study evaluates systemic therapy surveillance in brain metastases patients
- Non-randomized trial of neuromodulation prehabilitation for brain tumor language networks
- Review of non-invasive prehabilitation for neuro-oncology patients at Institut Guttmann in Barcelona
- Review of SIMMA utility for paediatric tumour monitoring via cfDNA profiling and ecDNA detection
- Stereotactic radiation improves symptoms versus hippocampal-avoidance whole brain radiation in patients with 5 to 20 brain metastases
- Neurosurgery patients with brain tumors show preoperative financial capacity deficits compared to healthy controls
- Systematic review finds variable MRI segmentation accuracy for pituitary adenomas and gland
- First-line osimertinib shows high response rates in EGFR-mutated NSCLC with active brain metastases
- EMILIN-1 shows dual tumor-suppressive and promoting roles in brain tumor biology review
- Hierarchical Barycentric Framework Shows Consistent Improvements in Brain Tumor MRI Analysis
- Elevated neutrophil-to-lymphocyte ratio predicts brain metastasis risk in lung cancer patients
- Hypofractionated stereotactic radiation therapy showed high local control in breast cancer brain metastases